NCT00839566 PAF-HEFT (Permanent Atrial Fibrillation in Heart Failure Trial) Status TERMINATED Phase PHASE4
NCT00837798 RATE Registry - Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) Episodes in the Cardiac Rhythm Management (CRM) Device Population Status COMPLETED Phase N/A
NCT00834925 Low Dose of Diltiazem for Rate Control of Atrial Fibrillation Status UNKNOWN Phase PHASE4
NCT00833313 Gene Expression Profiling in Subjects With Postoperative Atrial Fibrillation After Cardiac Surgery (GENEXPRO Surg) Status UNKNOWN Phase N/A
NCT00829933 Late Phase 2 Study of DU-176b in Patients With Non-Valvular Atrial Fibrillation Status COMPLETED Phase PHASE2
NCT00829478 Improving the Quality of Care for Atrial Fibrillation by Promoting Patient-Centered Decision Making Status COMPLETED Phase PHASE1
NCT00826826 The Effect of Short Term Amiodarone Treatment After Catheter Ablation for Atrial Fibrillation Status COMPLETED Phase NA
NCT00825968 Data Collection and Analysis of Patients Who Have Had an Electrophysiological Procedure Status TERMINATED Phase N/A
NCT00821353 Antiarrhythmic Therapy Versus Catheter Ablation for Atrial Fibrillation in Hypertrophic Cardiomyopathy Status COMPLETED Phase PHASE3
NCT00820625 Long-Standing Persistant Atrial Fibrillation-Pulmonary Vein Isolation With or Without Ablation Status COMPLETED Phase NA
NCT00818012 Atrial Electromechanical Interval and Pulse Wave Velocity in the Prediction of Recurrence of Atrial Fibrillation Status COMPLETED Phase N/A
NCT00816192 Comparison of Externally Versus Internally Cooled Tip Catheter Ablation in Paroxysmal Atrial Fibrillation Status TERMINATED Phase NA
NCT00814177 Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients Status COMPLETED Phase PHASE2
NCT00812916 European Carto® XP REgistry for Validating Specialized CFAE SOftware Status COMPLETED Phase N/A
NCT00811382 Clinical effecT of Heart Failure Management Via Home Monitoring With a Focus on Atrial Fibrillation (effecT) Status TERMINATED Phase NA
NCT00808067 RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial Status COMPLETED Phase PHASE3